Who should not take Dihexa?
Documented caution flags for Dihexa include active malignancy (theoretical concern) and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Dihexa is limited.
Documented caution flags for Dihexa
- Active malignancy (theoretical concern)
- Pregnancy / nursing
- Anyone risk-averse to early-data peptides
Reported side effects to weigh
- Limited human safety data
- Anecdotal: headache, irritability
- Theoretical: tumor-growth concern (synaptogenic + general growth signal)
References
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases — Wright JW, Kawas LH, Harding JW. Progress in Neurobiology, 2015
- A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases — Wright JW, Harding JW. Frontiers in Endocrinology, 2013
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Dihexa
Last updated 2026-06-15.